>

Stem cell (hematopoietic)

Q: Can I use the Stem cell (hematopoietic) icon in a BioRender figure or scientific illustration?

Yes — the Stem cell (hematopoietic) is fully integrated into BioRender's drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you're building from scratch or starting with a BioRender template.

Q: Can I export figures that include the Stem cell (hematopoietic) icon for publication or presentations?

Yes — figures containing the Stem cell (hematopoietic) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Stem cell (hematopoietic) - Editable icon of a generic round stem cell with a large circular nucleus in the center

[{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf10/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf10/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf0f/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf0f/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf0e/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf0e/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf0d/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf0d/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf0c/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf0c/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf0b/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf0b/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf0a/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf0a/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf09/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf09/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf08/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf08/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf07/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf07/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf06/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf06/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf05/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf05/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf04/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf04/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf03/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf03/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf02/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf02/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf01/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf01/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faf00/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faf00/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faeff/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faeff/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faefe/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faefe/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faefd/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faefd/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faefc/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faefc/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faefb/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faefb/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faefa/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faefa/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef9/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef9/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef8/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef8/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef7/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef7/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef6/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef6/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef5/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef5/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef4/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef4/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef3/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef3/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef2/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef2/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef1/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef1/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faef0/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faef0/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faeef/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faeef/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faeee/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faeee/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faeed/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faeed/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faeec/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faeec/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faeeb/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faeeb/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faeea/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faeea/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee9/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee9/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee8/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee8/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee7/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee7/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee6/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee6/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee5/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee5/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee4/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee4/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee3/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee3/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee2/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee2/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee1/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee1/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faee0/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faee0/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faedf/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faedf/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faede/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faede/61798ddc4b488100281faedc.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/61798e6b4b488100281faedd/61798ddc4b488100281faedc.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/61798e6b4b488100281faedd/61798ddc4b488100281faedc.png"}]

Keywords

keyword text

stem cell,undifferentiated,hematopoietic,hematopoietic stem cell,blood stem cell,stem,HSC,haematopoiesis,cell,blood,blood cell,red bone marrow,bone marrow,circulatory,internalcellupdate-21q3,popular immunology icons,stem cell

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in

Related Categories

Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Stem cell (hematopoietic) icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Stem cell (hematopoietic) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Stem cell (hematopoietic) icon customizable in BioRender?

Most icons in BioRender, including the Stem cell (hematopoietic) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the Stem cell (hematopoietic) icon in their work?

BioRender users often use the Stem cell (hematopoietic) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Can I export figures that include the Stem cell (hematopoietic) icon for publication or presentations?

Yes, figures containing the Stem cell (hematopoietic) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the Stem cell (hematopoietic) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Stem cell (hematopoietic) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

Make scientific figures in minutes

Stem cell (hematopoietic)

Join 1,500,000 other scientists on BioRender

FAQs

Looking for science content?